ArticleHemaSphere2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma.
Gala Vega et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it